Xobaderm Limited - Accounts to registrar (filleted) - small 18.2

Xobaderm Limited - Accounts to registrar (filleted) - small 18.2

XOBADERM LIMITED - Company Information

Print Friendly Version

IRIS Accounts Production v19.1.2.3 08865450 Board of Directors 1.2.18 31.1.19 31.1.19 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure088654502018-01-31088654502019-01-31088654502018-02-012019-01-31088654502017-01-31088654502017-02-012018-01-31088654502018-01-3108865450ns15:EnglandWales2018-02-012019-01-3108865450ns14:PoundSterling2018-02-012019-01-3108865450ns10:Director12018-02-012019-01-3108865450ns10:PrivateLimitedCompanyLtd2018-02-012019-01-3108865450ns10:SmallEntities2018-02-012019-01-3108865450ns10:AuditExempt-NoAccountantsReport2018-02-012019-01-3108865450ns10:SmallCompaniesRegimeForDirectorsReport2018-02-012019-01-3108865450ns10:SmallCompaniesRegimeForAccounts2018-02-012019-01-3108865450ns10:FullAccounts2018-02-012019-01-310886545012018-02-012019-01-3108865450ns10:Director22018-02-012019-01-3108865450ns10:RegisteredOffice2018-02-012019-01-3108865450ns5:CurrentFinancialInstruments2019-01-3108865450ns5:CurrentFinancialInstruments2018-01-3108865450ns5:ShareCapital2019-01-3108865450ns5:ShareCapital2018-01-3108865450ns5:SharePremium2019-01-3108865450ns5:SharePremium2018-01-3108865450ns5:RetainedEarningsAccumulatedLosses2019-01-3108865450ns5:RetainedEarningsAccumulatedLosses2018-01-3108865450ns5:PatentsTrademarksLicencesConcessionsSimilar2018-02-012019-01-3108865450ns5:PatentsTrademarksLicencesConcessionsSimilar2018-01-3108865450ns5:PatentsTrademarksLicencesConcessionsSimilar2019-01-3108865450ns5:PatentsTrademarksLicencesConcessionsSimilar2018-01-3108865450ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-01-3108865450ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-01-31


REGISTERED NUMBER: 08865450 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2019

FOR

XOBADERM LIMITED
XOBADERM LIMITED (REGISTERED NUMBER: 08865450)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


XOBADERM LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2019







DIRECTORS: Dr A J Kirby
Dr S T Bennett





REGISTERED OFFICE: 4 Westminster Drive
Cardiff
CF23 6RD





REGISTERED NUMBER: 08865450 (England and Wales)





ACCOUNTANTS: Graham Paul Chartered Accountants
5 Ash Tree Court
Woodsy Close
Cardiff Gate Business Park
Cardiff
CF23 8RW
-1-
XOBADERM LIMITED (REGISTERED NUMBER: 08865450)

BALANCE SHEET
31 JANUARY 2019

2019 2018
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 62,133 53,307

CURRENT ASSETS
Debtors 5 1,177 4,188
Cash at bank 5,954 24,300
7,131 28,488
CREDITORS
Amounts falling due within one year 6 8,988 8,835
NET CURRENT (LIABILITIES)/ASSETS (1,857 ) 19,653
TOTAL ASSETS LESS CURRENT
LIABILITIES
60,276
72,960

CAPITAL AND RESERVES
Called up share capital 1 1
Share premium 82,886 86,808
Retained earnings (22,611 ) (13,849 )
SHAREHOLDERS' FUNDS 60,276 72,960

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 24 October 2019 and were signed on its
behalf by:





Dr A J Kirby - Director


The notes form part of these financial statements

-2-
XOBADERM LIMITED (REGISTERED NUMBER: 08865450)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2019


1. STATUTORY INFORMATION

Xobaderm Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information
page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company has net current liabilities and relies on the ongoing support of a director. The director has
confirmed that he will continuing to provide this support as required for the 12 months from the date of
approval of these accounts. This, along with additional investment funding anticipated after the year
end means the accounts are prepared on a going concern basis.

Intangible fixed assets - patents and licences
Expenditure relating to patents and other forms of intellectual property protection are capitalised at
cost. They are then amortised over their anticipated useful life of ten years, commencing from when
economic benefits start to arise.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,
except to the extent that it relates to items recognised in other comprehensive income or directly in
equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that are
expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2018 - NIL).

-3-
XOBADERM LIMITED (REGISTERED NUMBER: 08865450)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2019


4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 February 2018 53,307
Additions 8,826
At 31 January 2019 62,133
NET BOOK VALUE
At 31 January 2019 62,133
At 31 January 2018 53,307

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Other debtors 1,177 4,188

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Other creditors 8,988 8,835

7. RELATED PARTY DISCLOSURES

During the current and previous year, the company was in receipt of an interest free loan from one of
it's directors. The amount outstanding and due to the director at the year end was £7,584 (2018 -
£7,584).

-4-